It’s a big question, and one that nearly every entrepreneur and economist grapples with: how long do businesses generally survive?
A group of scientists appear to have at least partially unlocked the answer, with a somewhat surprising result: publicly-traded companies die —through acquisitions, mergers, bankruptcy or other reasons — at the same rate irrespective of how well-established they are, or what they actually do.
The magic number, a new study from scientists at the Santa Fe Institute in New Mexico reveals, is about 10 years.
The study, published in the journal Royal Science Interface and conducted by three researchers, was led by then-undergraduate fellow Madeleine Daepp under the guidance of Marcus Hamilton, Professor Luis Bettencourt and Distinguished Professor Geoffrey West.
“We gave her this basic idea, and she did the heavy lifting,” Hamilton, a postdoctoral research fellow at the institute, told Science Daily.
Daepp, now a graduate student at the University of British Columbia, analyzed Standard and Poor’s Compustat — a database of every publicly traded company since 1950 — using a statistical method called survival analysis. What she and her advisers found is that a company’s mortality rate was not affected by it’s past performance or even its products.
“It doesn’t matter if you’re selling bananas, airplanes, or whatever,” Hamilton said.
The reason behind their findings remains beyond their study’s scope, but the researchers hypothesize that the biological world’s systems and competition for resources might provide some sort of insight.
- Zero-COVID Protests in China Have Rattled Global Markets
- Column: Diversity Initiatives Are Failing the U.S. Muslim Community
- Why European Countries Are Giving Teens Free Money To Spend on Books, Music, and Theater
- Republican Skepticism of Trump Has Never Been Higher
- Column: The U.S. Prison System Doesn't Value True Justice
- How Green Is the Qatar World Cup’s Outdoor AC?
- 16 Funny and Whimsical White Elephant Gifts Under $25
- The 5 Best New TV Shows Our Critic Watched in November 2022